Five Killer50 companies acquired and 30 others raise a combined $1.9bn in 2024

26 Nov, 2024
Newsdesk
2024 has proved a fruitful fundraising year for Business Weekly’s Killer50 Technology and Life Science companies.
Thumbnail

Ten of the 50 Cambridge technology elite and 20 of the 50 life science companies have raised growth capital as they seek to scale globally via increased recruitment, establishing new global facilities or, in the case of the biotechs, advancing clinical trials.

Five of our major Killer50 companies have been acquired, four by US buyers – Darktrace, Endomag, Featurespace and IQGeo.

The Killer50 life science companies have raised a combined $1.15 billion with Bicycle Therapeutics’ PIPE raise accounting for almost half of that figure. Other major raises recently include Nuclera closing a $75m Series C round, Constructive Bio securing $58m in the first close of its Series A, Healx winning $47m Series C funding and Cerevance a $47m extension to its Series B. Two significant 2024 seed rounds featured ExpressionEdits ($13m) and Shift Bioscience ($16m).

The Killer50 Technology companies have raised a combined $754m to date this year with the largest hauls achieved by Quantinuum ($300m) and Raspberry Pi ($225m) via a London IPO in June. Funding rounds in Cambridge Mechatronics Ltd ($40m), Echion Technologies ($37.8m), Luminance ($40m) and Riverlane ($75m) were other significant completions.

The most recent raise has seen Cambridge fabless semiconductor company Forefront RF unveil a £16 million Series A. Tech entrepreneur Phil O’Donovan, chair of the company, is predicting that the young business can blaze a similar trail to greatness as his former game-changing enterprise Cambridge Silicon Radio.

The Killer50: Technology companies

1Spatial 
42 Technology 
Advanced Infrastructure

Arm
  
AVEVA (Schneider Electric)
Bango
Cambridge Consultants
Cambridge GaN Devices 
Cambridge Intelligence 
Cambridge Mechatronics
  
Darktrace   
Domino Printing  
Echion Technologies  
Featurespace  
FlexEnable  
Flusso  
FocalPoint  
Forefront RF  
Frontier Developments  
Gearset  
Intellegens   
IQGeo   
Jagex  
Johnson Matthey   
Levidian   
lowRISC CIC   
Luminance   
Marshall Group   
Monumo   
Nu Quantum   
Nyobolt  
Paragraf   
Porotech   
Pragmatic      
Quantinuum   
Raspberry Pi   
Redgate   
Riverlane   
Secondmind   
Sepura   
Speechmatics   
Superdielectrics   
Thermoteknix Systems    
Trustonic  
TTP   
VividQ   
VNC Automotive   
Wave Photonics   
Xaar   
Xampla   

The Killer50: Life Science companies

4basebio   
Abcam   
Alchemab Therapeutics   
Altos Labs   
Apollo Therapeutics   
Artios Pharma   
Astex Pharmaceuticals   
AstraZeneca   
Bicycle Therapeutics   
Biofidelity   
BIOS Health   
bit.bio   
Broken String Biosciences   
CellCentric   
Cellular Origins   
Cerevance   
CMR Surgical   
CN Bio   
Constructive Bio   
Cresset Group   
CS Genetics   
DNA Ascendancy   
Domainex   
Dunad Therapeutics   
Endomag   
Epitopea   
ExpressionEdits   
Healx  
Lightcast Discovery   
LoQus23 Therapeutics   
Lucida Medical   
Mestag Therapeutics   
Microbiotica   
Mission Therapeutics   
Mosaic Therapeutics   
Nuclera   
Nxera Pharma   
OutSee Limited   
Owlstone Medical   
PhoreMost   
Quotient Therapeutics   
Qureight   
RxCelerate   
Sano Genetics   
Shift Bioscience   
Sphere Fluidics   
SPT Labtech   
STORM Therapeutics   
T-Therapeutics   
ViaNautis Bio